Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Receptor-binding sites on C3 and C3b

M P Dierich, V A Bokisch

    Journal of Immunology (Baltimore, Md. : 1950)
    |June 1, 1977
    PubMed
    Summary

    This study explores how human cells interact with complement proteins C3 and C3b. Using erythrocytes and Daudi cells, the researchers found that these cells have two distinct receptor sites for C3b and C3d. When C3b binds to cells, one receptor site becomes hidden, but it reappears after C3b is cleaved into C3c and C3d. The study also found that C3c remains attached to the cell surface for some time after cleavage. These findings suggest that the structure of C3b is important for receptor interactions. The researchers propose that a receptor site may be located at the junction between C3c and C3d, and cleavage could affect its availability. These results help clarify how complement proteins regulate immune responses at the cellular level.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Absence of indigenous specific West Nile virus antibodies in Tyrolean blood donors.

    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2011
    Same author

    A 1-year Aspergillus terreus surveillance study at the University Hospital of Innsbruck: molecular typing of environmental and clinical isolates.

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2008
    Same author

    Ointments as a source of meticillin-resistant Staphylococcus aureus spread.

    The Journal of hospital infection·2008
    Same author

    Immune evasion by acquisition of complement inhibitors: the mould Aspergillus binds both factor H and C4b binding protein.

    Molecular immunology·2007
    Same author

    Influence of amphotericin B and amphotericin B colloidal dispersion on the functions of human phagocytes in defence against Aspergillus species.

    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2007
    Same author

    Targeting human immunodeficiency virus type 1 with antibodies derived from patients with connective tissue disease.

    Lupus·2007

    Area of Science:

    • Immunology
    • Cell biology
    • Complement system research

    Background:

    The complement system plays a central role in innate immunity, yet the exact mechanisms governing C3 receptor interactions remain unclear. Prior research has shown that C3 and its cleavage products bind to cell surfaces, but the stability and accessibility of these binding sites are not fully understood. Some studies suggest that C3b and C3d receptors function differently depending on cell type and binding state. However, no prior work had resolved how receptor availability changes with C3b cleavage. This gap motivated further investigation into the structural dynamics of C3b binding. Understanding these interactions could clarify how immune responses are regulated at the cellular level. The complement system's role in immune signaling remains a key area of interest. The need to distinguish between stable and labile binding sites led to this study's focus.

    Purpose Of The Study:

    This study aimed to investigate the binding properties of C3 and C3b on human erythrocytes and Daudi cells. The researchers wanted to determine whether these cells possess distinct receptor sites for C3b and C3d. By using two cell types with known receptor profiles, the team sought to clarify how receptor availability changes with C3b cleavage. The study's motivation stemmed from the need to understand how receptor binding is affected by structural changes in C3b. The researchers focused on identifying stable and labile binding sites on these cells. They also aimed to analyze how cleavage products influence receptor exposure. The goal was to provide insights into the dynamic interactions between complement proteins and cell surfaces. This approach could help distinguish between receptor-specific and structural effects.

    Keywords:
    complement systemC3b receptorscell surface bindingimmune signaling

    Frequently Asked Questions

    The study identifies SBS1, specific for C3b receptors, and SBS2, specific for C3d receptors.

    Cleavage of C3b into C3c and C3d restores SBS2 accessibility but delays C3c release.

    Delayed release suggests structural changes in surface-bound C3b that affect receptor interactions.

    The researchers propose that SBS1 may reside at this junction, and cleavage could alter its availability.

    The study shows that structural integrity of C3b is crucial for SBS1 expression and receptor accessibility.

    Related Experiment Videos

    Main Methods:

    The researchers used human erythrocytes and Daudi lymphoid cells as model systems. They isolated and cleaved human C3 to generate C3b and C3d. Binding experiments were conducted to assess receptor occupancy on both cell types. Fetal calf serum and a partially purified C3b-inactivator were used to induce cleavage of surface-bound C3b. Kinetic measurements tracked the accessibility of binding sites over time. The study focused on the transition of SBS2 from concealed to accessible states. Surface-bound C3b was analyzed for cleavage into C3c and C3d. The team monitored the delayed release of C3c to assess structural stability.

    Main Results:

    Freshly cleaved C3b binds via a labile site, concealing SBS2 on cell surfaces. Kinetic data show that SBS2 becomes accessible again after cleavage of surface-bound C3b. This reappearance coincides with the cleavage of C3b into C3c and C3d. However, C3c remains attached to the cell surface and is released only with delay. The number of SBS1 receptors decreases during cleavage events. This suggests that structural integrity of C3b is crucial for SBS1 expression. An alternative explanation is that SBS1 resides at the junction between C3c and C3d. Cleavage of this region may alter SBS1 availability.

    Conclusions:

    The study suggests that C3b binding involves two distinct receptor sites on cell surfaces. The findings indicate that cleavage of C3b influences receptor accessibility dynamically. SBS2 becomes concealed upon initial binding but reappears after cleavage into C3c and C3d. The delayed release of C3c implies structural changes in surface-bound C3b. SBS1 availability appears to depend on the intact structure of C3b. The researchers propose that SBS1 may be located at the C3c-C3d junction. Cleavage of this region could alter receptor interactions. These results highlight the importance of structural integrity in C3b receptor binding.

    Failed At:

    2026-07-10T15:00:49.004083+00:00

    The results suggest that cleavage events dynamically regulate receptor availability on cell surfaces.